Skip to main content

Erratum to: Metastatic Merkel cell carcinoma response to nivolumab

The Original Article was published on 15 November 2016


Following publication of this article [1], it was noticed that the Clinical Trial Number in the last paragraph of the conclusions section was incorrectly listed as NCT02155647. The correct Clinical Trials Number is NCT02488759.


  1. Walocko FM, Scheier BY, Harms PW, Fecher LA, Lao CD. Metastatic Merkel cell carcinoma response to nivolumab. J Immunother Cancer. 2016;4:79. doi:10.1186/s40425-016-0186-1.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Christopher D. Lao.

Additional information

The online version of the original article can be found under doi:10.1186/s40425-016-0186-1.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Walocko, F.M., Scheier, B.Y., Harms, P.W. et al. Erratum to: Metastatic Merkel cell carcinoma response to nivolumab. j. immunotherapy cancer 5, 27 (2017).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: